Antibiotics and the developing infant gut microbiota and resistome

Current Opinion in Microbiology

Volumn 27, Issue , 2015, Pages 51-56

  Gibson, Molly K ^a   Crofts, Terence S ^a   Dantas, Gautam ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY IN ST LOUIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; BISMUTH; CEFALEXIN; CEFOPERAZONE; CLINDAMYCIN; ERYTHROMYCIN; GENTAMICIN; METRONIDAZOLE; PENICILLIN DERIVATIVE; STREPTOMYCIN; TEICOPLANIN; TETRACYCLINE; VANCOMYCIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC RESISTOME; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; BACTERIAL LOAD; HUMAN; INFANT; INTESTINE FLORA; LONG TERM CARE; MICROBIAL COMMUNITY; NONHUMAN; PREMATURITY; REVIEW; VERY LOW BIRTH WEIGHT; ADULT; BACTERIAL GENE; DRUG EFFECTS; GENETICS; METAGENOMICS; NEWBORN; PHYSIOLOGY;

ADULT; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MICROBIAL; GASTROINTESTINAL MICROBIOME; GENES, BACTERIAL; HUMANS; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, VERY LOW BIRTH WEIGHT; METAGENOMICS;

EID: 84938399395     PISSN: 13695274     EISSN: 18790364     Source Type: Journal    
DOI: 10.1016/j.mib.2015.07.007     Document Type: Review

References (57)

1. Zhang T., Smith M.A., Camp P.G., Shajari S., MacLeod S.M., Carleton B.C. Prescription drug dispensing profiles for one million children: a population-based analysis. Eur J Clin Pharmacol 2013, 69:581-588.
2. Clark R.H., Bloom B.T., Spitzer A.R., Gerstmann D.R. Reported medication use in the neonatal intensive care unit: data from a large national data set. Pediatrics 2006, 117:1979-1987.
3. Chai G., Governale L., McMahon A.W., Trinidad J.P., Staffa J., Murphy D. Trends of outpatient prescription drug utilization in US children, 2002-2010. Pediatrics 2012, 130:23-31.
4. Cox L.M., Yamanishi S., Sohn J., Alekseyenko A.V., Leung J.M., Cho I., Kim S.G., Li H., Gao Z., Mahana D., et al. Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences. Cell 2014, 158:705-721.
5. Sommer M.O., Church G.M., Dantas G. The human microbiome harbors a diverse reservoir of antibiotic resistance genes. Virulence 2010, 1:299-303.
6. Smillie C.S., Smith M.B., Friedman J., Cordero O.X., David L.A., Alm E.J. Ecology drives a global network of gene exchange connecting the human microbiome. Nature 2011, 480:241-244.
7. Stecher B., Denzler R., Maier L., Bernet F., Sanders M.J., Pickard D.J., Barthel M., Westendorf A.M., Krogfelt K.A., Walker A.W., et al. Gut inflammation can boost horizontal gene transfer between pathogenic and commensal Enterobacteriaceae. Proc Natl Acad Sci U S A 2012, 109:1269-1274.
8. Karami N., Martner A., Enne V.I., Swerkersson S., Adlerberth I., Wold A.E. Transfer of an ampicillin resistance gene between two Escherichia coli strains in the bowel microbiota of an infant treated with antibiotics. J Antimicrob Chemother 2007, 60:1142-1145.
9. Modi S.R., Collins J.J., Relman D.A. Antibiotics and the gut microbiota. J Clin Invest 2014, 124:4212-4218.
10. Jakobsson H.E., Jernberg C., Andersson A.F., Sjolund-Karlsson M., Jansson J.K., Engstrand L. Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome. PLoS One 2010, 5:e9836.
11. Lofmark S., Jernberg C., Jansson J.K., Edlund C. Clindamycin-induced enrichment and long-term persistence of resistant Bacteroides spp. and resistance genes. J Antimicrob Chemother 2006, 58:1160-1167.
12. Jernberg C., Lofmark S., Edlund C., Jansson J.K. Long-term impacts of antibiotic exposure on the human intestinal microbiota. Microbiology 2010, 156:3216-3223.
13. Yatsunenko T., Rey F.E., Manary M.J., Trehan I., Dominguez-Bello M.G., Contreras M., Magris M., Hidalgo G., Baldassano R.N., Anokhin A.P., et al. Human gut microbiome viewed across age and geography. Nature 2012, 486:222-227.
14. La Rosa P.S., Warner B.B., Zhou Y., Weinstock G.M., Sodergren E., Hall-Moore C.M., Stevens H.J., Bennett W.E., Shaikh N., Linneman L.A., et al. Patterned progression of bacterial populations in the premature infant gut. Proc Natl Acad Sci U S A 2014, 111:12522-12527.
15. Palmer C., Bik E.M., DiGiulio D.B., Relman D.A., Brown P.O. Development of the human infant intestinal microbiota. PLoS Biol 2007, 5:e177.
16. Dominguez-Bello M.G., Costello E.K., Contreras M., Magris M., Hidalgo G., Fierer N., Knight R. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci U S A 2010, 107:11971-11975.
17. Makino H., Kushiro A., Ishikawa E., Kubota H., Gawad A., Sakai T., Oishi K., Martin R., Ben-Amor K., Knol J., et al. Mother-to-infant transmission of intestinal bifidobacterial strains has an impact on the early development of vaginally delivered infant's microbiota. PLoS One 2013, 8:e78331.
18. Brooks B., Firek B.A., Miller C.S., Sharon I., Thomas B.C., Baker R., Morowitz M.J., Banfield J.F. Microbes in the neonatal intensive care unit resemble those found in the gut of premature infants. Microbiome 2014, 2:1.
19. Schwiertz A., Gruhl B., Lobnitz M., Michel P., Radke M., Blaut M. Development of the intestinal bacterial composition in hospitalized preterm infants in comparison with breast-fed, full-term infants. Pediatr Res 2003, 54:393-399.
20. Koenig J.E., Spor A., Scalfone N., Fricker A.D., Stombaugh J., Knight R., Angenent L.T., Ley R.E. Succession of microbial consortia in the developing infant gut microbiome. Proc Natl Acad Sci U S A 2011, 108(Suppl 1):4578-4585.
21. Morowitz M.J., Denef V.J., Costello E.K., Thomas B.C., Poroyko V., Relman D.A., Banfield J.F. Strain-resolved community genomic analysis of gut microbial colonization in a premature infant. Proc Natl Acad Sci U S A 2011, 108:1128-1133.
22. Zhang L., Kinkelaar D., Huang Y., Li Y., Li X., Wang H.H. Acquired antibiotic resistance: are we born with it?. Appl Environ Microbiol 2011, 77:7134-7141.
23. Moore A.M., Patel S., Forsberg K.J., Wang B., Bentley G., Razia Y., Qin X., Tarr P.I., Dantas G. Pediatric fecal microbiota harbor diverse and novel antibiotic resistance genes. PLoS One 2013, 8:e78822.
24. Mitsou E.K., Kirtzalidou E., Pramateftaki P., Kyriacou A. Antibiotic resistance in faecal microbiota of Greek healthy infants. Benef Microbes 2010, 1:297-306.
25. Pehrsson E.C., Forsberg K.J., Gibson M.K., Ahmadi S., Dantas G. Novel resistance functions uncovered using functional metagenomic investigations of resistance reservoirs. Front Microbiol 2013, 4:145.
26. Kuppala V.S., Meinzen-Derr J., Morrow A.L., Schibler K.R. Prolonged initial empirical antibiotic treatment is associated with adverse outcomes in premature infants. J Pediatr 2011, 159:720-725.
27. Greenwood C., Morrow A.L., Lagomarcino A.J., Altaye M., Taft D.H., Yu Z., Newburg D.S., Ward D.V., Schibler K.R. Early empiric antibiotic use in preterm infants is associated with lower bacterial diversity and higher relative abundance of Enterobacter. J Pediatr 2014, 165:23-29.
28. Bennet R., Eriksson M., Nord C.E., Zetterstrom R. Fecal bacterial microflora of newborn infants during intensive care management and treatment with five antibiotic regimens. Pediatr Infect Dis 1986, 5:533-539.
29. Tanaka S., Kobayashi T., Songjinda P., Tateyama A., Tsubouchi M., Kiyohara C., Shirakawa T., Sonomoto K., Nakayama J. Influence of antibiotic exposure in the early postnatal period on the development of intestinal microbiota. FEMS Immunol Med Microbiol 2009, 56:80-87.
30. Arboleya S., Sanchez B., Milani C., Duranti S., Solis G., Fernandez N., de Los Reyes-Gavilan C.G., Ventura M., Margolles A., Gueimonde M. Intestinal microbiota development in preterm neonates and effect of perinatal antibiotics. J Pediatr 2014, 166:538-544.
31. Cho I., Yamanishi S., Cox L., Methe B.A., Zavadil J., Li K., Gao Z., Mahana D., Raju K., Teitler I., et al. Antibiotics in early life alter the murine colonic microbiome and adiposity. Nature 2012, 488:621-626.
32. Antonopoulos D.A., Huse S.M., Morrison H.G., Schmidt T.M., Sogin M.L., Young V.B. Reproducible community dynamics of the gastrointestinal microbiota following antibiotic perturbation. Infect Immun 2009, 77:2367-2375.
33. Russell S.L., Gold M.J., Hartmann M., Willing B.P., Thorson L., Wlodarska M., Gill N., Blanchet M.R., Mohn W.W., McNagny K.M., et al. Early life antibiotic-driven changes in microbiota enhance susceptibility to allergic asthma. EMBO Rep 2012, 13:440-447.
34. Zhang L., Huang Y., Zhou Y., Buckley T., Wang H.H. Antibiotic administration routes significantly influence the levels of antibiotic resistance in gut microbiota. Antimicrob Agents Chemother 2013, 57:3659-3666.
35. Ready D., Lancaster H., Qureshi F., Bedi R., Mullany P., Wilson M. Effect of amoxicillin use on oral microbiota in young children. Antimicrob Agents Chemother 2004, 48:2883-2887.
36. Lin P.W., Nasr T.R., Stoll B.J. Necrotizing enterocolitis: recent scientific advances in pathophysiology and prevention. Semin Perinatol 2008, 32:70-82.
37. Cotten C.M., Taylor S., Stoll B., Goldberg R.N., Hansen N.I., Sanchez P.J., Ambalavanan N., Benjamin D.K., Network N.N.R. Prolonged duration of initial empirical antibiotic treatment is associated with increased rates of necrotizing enterocolitis and death for extremely low birth weight infants. Pediatrics 2009, 123:58-66.
38. Hartel C., Pagel J., Rupp J., Bendiks M., Guthmann F., Rieger-Fackeldey E., Heckmann M., Franz A., Schiffmann J.H., Zimmermann B., et al. Prophylactic use of Lactobacillus acidophilus/Bifidobacterium infantis probiotics and outcome in very low birth weight infants. J Pediatr 2014, 165:285-289. e281.
39. Abrahamsson T.R., Rautava S., Moore A.M., Neu J., Sherman P.M. The time for a confirmative necrotizing enterocolitis probiotics prevention trial in the extremely low birth weight infant in North America is now!. J Pediatr 2014, 165:389-394.
40. Jones R.M., Luo L., Ardita C.S., Richardson A.N., Kwon Y.M., Mercante J.W., Alam A., Gates C.L., Wu H., Swanson P.A., et al. Symbiotic lactobacilli stimulate gut epithelial proliferation via Nox-mediated generation of reactive oxygen species. EMBO J 2013, 32:3017-3028.
41. Deshmukh H.S., Liu Y., Menkiti O.R., Mei J., Dai N., O'Leary C.E., Oliver P.M., Kolls J.K., Weiser J.N., Worthen G.S. The microbiota regulates neutrophil homeostasis and host resistance to Escherichia coli K1 sepsis in neonatal mice. Nat Med 2014, 20:524-530.
42. Russell S.L., Gold M.J., Reynolds L.A., Willing B.P., Dimitriu P., Thorson L., Redpath S.A., Perona-Wright G., Blanchet M.R., Mohn W.W., et al. Perinatal antibiotic-induced shifts in gut microbiota have differential effects on inflammatory lung diseases. J Allergy Clin Immunol 2015, 135:100-109.
43. Trasande L., Blustein J., Liu M., Corwin E., Cox L.M., Blaser M.J. Infant antibiotic exposures and early-life body mass. Int J Obes (Lond) 2013, 37:16-23.
44. Azad M.B., Bridgman S.L., Becker A.B., Kozyrskyj A.L. Infant antibiotic exposure and the development of childhood overweight and central adiposity. Int J Obes (Lond) 2014, 38:1290-1298.
45. Toprak E., Veres A., Michel J.B., Chait R., Hartl D.L., Kishony R. Evolutionary paths to antibiotic resistance under dynamically sustained drug selection. Nat Genet 2012, 44:101-105.
46. Lee H.H., Molla M.N., Cantor C.R., Collins J.J. Bacterial charity work leads to population-wide resistance. Nature 2010, 467:82-85.
47. Barbosa T.M., Levy S.B. The impact of antibiotic use on resistance development and persistence. Drug Resist Updat 2000, 3:303-311.
48. Shoemaker N.B., Vlamakis H., Hayes K., Salyers A.A. Evidence for extensive resistance gene transfer among Bacteroides spp. and among Bacteroides and other genera in the human colon. Appl Environ Microbiol 2001, 67:561-568.
49. Lester C.H., Frimodt-Moller N., Sorensen T.L., Monnet D.L., Hammerum A.M. In vivo transfer of the vanA resistance gene from an Enterococcus faecium isolate of animal origin to an E. faecium isolate of human origin in the intestines of human volunteers. Antimicrob Agents Chemother 2006, 50:596-599.
50. Jernberg C., Lofmark S., Edlund C., Jansson J.K. Long-term ecological impacts of antibiotic administration on the human intestinal microbiota. ISME J 2007, 1:56-66.
51. Nesme J., Cecillon S., Delmont T.O., Monier J.M., Vogel T.M., Simonet P. Large-scale metagenomic-based study of antibiotic resistance in the environment. Curr Biol 2014, 24:1096-1100.
52. Gibson M.K., Forsberg K.J., Dantas G. Improved annotation of antibiotic resistance determinants reveals microbial resistomes cluster by ecology. ISME J 2014, 9:207-216.
53. Hu Y., Yang X., Qin J., Lu N., Cheng G., Wu N., Pan Y., Li J., Zhu L., Wang X., et al. Metagenome-wide analysis of antibiotic resistance genes in a large cohort of human gut microbiota. Nat Commun 2013, 4:2151.
54. Sommer M.O., Dantas G., Church G.M. Functional characterization of the antibiotic resistance reservoir in the human microflora. Science 2009, 325:1128-1131.
55. Forslund K., Sunagawa S., Kultima J.R., Mende D.R., Arumugam M., Typas A., Bork P. Country-specific antibiotic use practices impact the human gut resistome. Genome Res 2013, 23:1163-1169.
56. Forsberg K.J., Patel S., Gibson M.K., Lauber C.L., Knight R., Fierer N., Dantas G. Bacterial phylogeny structures soil resistomes across habitats. Nature 2014, 509:612-616.
57. Moore A.M., Ahmadi S., Patel S., Gibson M.K., Wang B., Ndao M.I., Deych E., Shannon W., Tarr P.I., Warner B.B., Dantas G. Gut resistome development in healthy twin pairs in the first year of life. Microbiome 2015, 3:27. 10.1186/s40168-015-0090-9.